Inside the Viral Tanning Peptide That Accidentally Created Vyleesi’s FDA-Approved Low Sex Drive Drug

Unverified "sunless tanning" injections are exploding across social media, but their real scientific legacy isn't a dark ...
Time

The New 'Female Viagra' Has Reignited a Debate Over Drugs and Female Sexuality

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
WebMD

Vyleesi Side Effects and Interactions: What to Expect and How to Manage Them

Vyleesi (bremelanotide) is a melanocortin receptor agonist used for hypoactive sexual desire disorder (HSDD) in women who have not gone through menopause. Women with HSDD struggle with an ongoing lack ...
technologynetworks

New Libido Drug Vyleesi Approved to Treat Hypoactive Sexual Desire in Women

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. “There are women who, for ...
WebMD

Navigating HSDD With Vyleesi: What You Need to Know

You may have heard about Vyleesi (bremelanotide), a medicine approved by the FDA to treat low sex drive, called hypoactive sexual desire disorder (HSDD), in premenopausal women. HSDD is the most ...
Nasdaq

AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi™ (Bremelanotide Injection) Data in Obstetrics & Gynecology

The RECONNECT Studies Demonstrated a Clinically Meaningful and Statistically Significant Improvement in the Co-Primary Endpoints of Desire and Associated Distress WALTHAM, Mass., Oct. 11, 2019 (GLOBE ...
FiercePharma

AMAG wins FDA nod for Vyleesi. Could it be the ‘female Viagra’ that Addyi never was?

Valeant, now Bausch Health, paid $1 billon in 2015 for Sprout Pharmaceuticals’ female libido drug Addyi, only to sell it back in 2017. Now as the drug is still nowhere near the blockbuster status ...
PopSugar

Vyleesi Disclosures

VYLEESI is a prescription medicine used to treat hypoactive (low) sexual desire disorder (HSDD) in women who have not gone through menopause, who have not had problems with low sexual desire in the ...
Forbes

Vyleesi Approval Expands Treatment Options For Female Hypoactive Sexual Desire Disorder

Two weeks ago, the Food and Drug Administration (FDA) approved Vyleesi (bremelanotide), a first-in-class injectable treatment indicated for hypoactive sexual desire disorder (HSDD) in pre-menopausal ...
Nasdaq

Vyleesi(TM) Phase 3 Data To Be Presented At The 13th European Society Of Gynecology Congress

CRANBURY, N.J., Oct. 16, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) announced today that data from two pivotal, double-blind placebo-controlled Phase 3 trials (RECONNECT) and ...
Forbes

Why This New FDA-approved Drug Vyleesi Is Not 'Female Viagra'

What's up with headlines calling Vyleesi a "female Viagra"? Yes, both medications begin with the letter "V" and are designed to address sex-related health issues. But there are real hard differences ...